在1型糖尿病患者的诺莫西亚和诺莫巴里克缺氧下进行训练
Paula Nowocień1, Dominika Rokicka1, Marta Wróbel2
1Department of Internal Medicine, Diabetology and Cardiometabolic Disorders, Faculty of Medical Sciences Zabrze, Medical University of Silesia in Katowice, Poland.
Endokrynologia Polska
|September 16, 2024
概括
身体炼对1型糖尿病管理有好处,但低血糖风险需要仔细准备. 在normobaric缺氧下进行运动可以通过激活缺氧诱导因子 (HIF-1) 来提高血糖控制和身体表现.
科学领域:
- 内分泌学 在内分泌学.
- 运动医学 运动医学
- 代谢研究研究 代谢研究
背景情况:
- 运动对于1型糖尿病 (T1DM) 管理至关重要,改善胰岛素敏感性和心血管健康.
- 低血糖是胰岛素治疗T1DM患者运动期间的重大风险,需要适当的准备和炼选择.
- 正常性缺氧 (模拟高度) 运动正在成为一种流行的训练方法.
研究的目的:
- 审查和总结最近关于运动对T1DM患者血糖控制和身体表现的影响的研究.
- 为了比较在T1DM中normoxia和normobaric hypoxia下的运动的影响.
- 探索缺氧诱导因子 (HIF-1) 在调解运动适应中的作用.
主要方法:
- 对最近研究的文献综述,重点关注T1DM,运动,血糖控制和体力表现.
- 分析涉及诺莫克西克和诺莫巴里克缺氧训练条件的研究.
- 检查对缺氧诱导因子 (HIF-1) 途径及其代谢影响的研究.
主要成果:
- 运动可以改善胰岛素敏感性,降低血糖,减少体脂,增强T1DM心血管功能.
- 常态性缺氧刺激HIF-1的产生,从而优化葡萄糖利用率,增加胰岛素敏感性,改善VO2max.
- 在缺氧下HIF-1激活也显示出对脂质样本和血管内皮的积极影响.
结论:
- 运动是T1DM的关键治疗辅助,仔细规划可以减轻低血糖风险.
- 在T1DM中,Normobaric缺氧运动为改善血糖控制和身体表现提供了一个有希望的途径.
- 在T1DM中,HIF-1在低氧运动期间观察到的代谢和性能益处中起着关键作用.
更多相关视频
12:59Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
Published on: July 5, 2017
12.6K
11:49Quantitative and Temporal Control of Oxygen Microenvironment at the Single Islet Level
Published on: November 17, 2013
9.1K
相关概念视频
01:23Hypoxia
972
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
972
01:22Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
01:22Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
01:15Diabetes: Management and Pharmacotherapy
245
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
245
01:21Acute Respiratory Failure-II
183
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
183
01:16Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
187
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
187